Cargando…
Late-onset isavuconazole-induced liver injury
Antifungal agents account for approximately 3% of Drug-Induced Liver Injury (DILI) cases. Isavuconazole is a novel triazole, and experience with long-term use of it is lacking. We report a case of late-onset DILI occurring after 11 months of isavuconazole therapy in a 55-year old man of Angolan desc...
Autores principales: | Bongomin, Felix, Rodriguez-Goncer, Isabel, Lorden, Carol, Otu, Akaninyene, Bazaz, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076222/ https://www.ncbi.nlm.nih.gov/pubmed/30094131 http://dx.doi.org/10.1016/j.mmcr.2018.07.006 |
Ejemplares similares
-
Utility of St. George’s respiratory questionnaire in predicting
clinical recurrence in chronic pulmonary aspergillosis
por: Bongomin, Felix, et al.
Publicado: (2021) -
Isavuconazole/piperacillin/tazobactam/voriconazole: Drug-induced liver injury: case report
Publicado: (2022) -
Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018) -
Isavuconazole/letermovir/remdesivir: Drug-induced liver injury and off-label use: case report
Publicado: (2021) -
Trichosporon japonicum Fungemia and Ventricular Assist Device Infection in an Immunocompetent Patient
por: Bongomin, Felix, et al.
Publicado: (2019)